Data Collective IV GP, LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Data Collective IV GP, LLC reported 6 stock positions worth $163.5 million. Its top holding was Oklo (OKLO) at 34.3% of the portfolio, followed by Evolv Technologies (EVLV, 24.0%) and Recursion Pharmaceuticals-A (RXRX, 24.0%). Its holdings were unchanged from Q2 2024.
- Most Recent 13F
- Q2 2026
- Location
- PALO ALTO, CA
- CIK
- 0001664974
- Portfolio Value
- $163.5M (Q3 2024)
- SEC Filing
- 0001104659-24-118260 ↗ filed Nov 14, 2024
Holdings Value
Holdings 6 stocks · $163.5M
| OKLO Oklo Inc. | 34.25% | 6,920,804 | $56.0M | No change |
| EVLV Evolv Technologies Holdings | 23.99% | 9,681,281 | $39.2M | No change |
| RXRX Recursion Pharmaceuticals-A | 23.95% | 5,941,120 | $39.2M | No change |
| RKLB Rocket Lab USA Inc. | 17.44% | 2,929,350 | $28.5M | No change |
| MIND MEDICINE MINDMED INC | 0.35% | 100,350 | $571K | No change |
| ROIV Roivant Sciences Ltd. | 0.03% | 3,875 | $45K | No change |
Portfolio Sells Q2 2024 → Q3 2024
| None this quarter. | |||
Portfolio Buys Q2 2024 → Q3 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $78.6M | EVLV, HQ, RXRX, DFTX |
| Q1 2026 | 4 | $55.9M | EVLV, RXRX, HQ, DFTX |
| Q4 2025 | 3 | $58.5M | EVLV, RXRX, MIND MEDICINE MINDMED INC |
| Q3 2025 | 4 | $68.0M | EVLV, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q2 2025 | 5 | $129.9M | EVLV, RKLB, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q1 2025 | 5 | $86.9M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |
| Q4 2024 | 6 | $226.3M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q3 2024 | 6 | $163.5M | OKLO, EVLV, RXRX, RKLB, MIND MEDICINE MINDMED INC |
| Q2 2024 | 6 | $142.7M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q1 2024 | 5 | $115.3M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |